Diabetis-All shortage status
1 active shortage notice across 1 country.
Last updated 16 Sept 2026 · sourced from official medicines regulators
- Generic name (INN)
- Diabetis-All
- Class
- Auto-created by CDSCO — Not of Standard Quality Drug Alerts scraper
Where Diabetis-All is in shortage
Why Diabetis-All is in shortage
- manufacturing problems — e.g. “The Sample gives TLC and HPLC [dentification Test for the Presence of Pioglitazone Hydrochloride. lFound Content of Pioglitazone Hydrochloride: 0.32mg/gm. The Sample is declared as…” (India)
Frequently asked questions
Is Diabetis-All currently in shortage?
Yes. As of the latest regulator updates, Diabetis-All has 1 active shortage notice across 1 country (India). Status is refreshed daily from official regulatory sources.
Why is Diabetis-All in shortage?
Regulators attribute the current Diabetis-All shortages to manufacturing problems. The exact cause varies by country and product — each notice on this page links to the official source.
Where does this Diabetis-All shortage data come from?
Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ regulators across 50+ countries and never publishes unsourced shortage claims.
Get alerted when Diabetis-All status changes
Free for individual pharmacists and clinicians — watchlists, email alerts, alternatives and country-by-country product detail.
Create a free accountData on this page is aggregated from official national medicines regulators and updated daily. It is provided for information only and requires verification before clinical use. Mederti is not affiliated with or endorsed by any regulator.